"Im Klinikum Bamberg setzen wir alles daran, Ihre Beschwerden erfolgreich zu behandeln. Dazu gehört auch, dass Sie und Ihre Angehörigen sich bei uns wohlfühlen. Deshalb verbinden wir bestmögliche medizinische Betreuung mit viel menschlicher Zuwendung und angenehmer familiärer Atmosphäre. Unsere Klinik-Standorte befinden sich in bester Lage der Weltkulturerbe-Stadt Bamberg. Von den Fenstern und Terrassen bietet sich das phantastisches Panorama unserer historischen Stadt bis ins Regnitztal und den fränkischen Jura. Für unsere Patienten sind das die besten Voraussetzungen, um gesund zu werden."

During the past decade, Sozialstiftung Bamberg conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sozialstiftung Bamberg" #1 sponsor was "AGO Research GmbH" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sozialstiftung Bamberg" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Lymphoma Study Association" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator, "UCB Pharma" with 1 trials as a collaborator and "University of Leipzig" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Sozialstiftung Bamberg" are "Lymphoma, Non-Hodgkin" (2 trials), "Atrial Fibrillation" (1 trials), "Multiple Myeloma" (1 trials), "Recurrent Ovarian Carcinoma" (1 trials) and "Stage IV or Recurrent Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Sozialstiftung Bamberg" in a lesser frequency.

Most popular intervention types in "Sozialstiftung Bamberg" are "Drug" (5 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (3 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Nivolumab" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sozialstiftung Bamberg" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sozialstiftung Bamberg". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sozialstiftung Bamberg, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sozialstiftung Bamberg, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Sozialstiftung Bamberg has several departments that took part in Clinical trials: "Sozialstiftung Bamberg Klinik fuer Haematologie und internistische Onkologie" - 2 trials